Neurovascular interventions encompass a range of procedures and techniques aimed at diagnosing and treating disorders affecting the blood vessels of the brain and spinal cord. These interventions are performed by specialized healthcare providers, often neurosurgeons or interventional neuroradiologists, and are crucial for managing conditions such as strokes, aneurysms, and arteriovenous malformations (AVMs). One common neurovascular intervention is endovascular therapy, which involves accessing the blood vessels of the brain or spine through minimally invasive techniques, such as catheterization, and delivering treatments directly to the site of the vascular abnormality. This may include techniques such as angioplasty to open narrowed or blocked vessels, embolization to block abnormal blood flow in AVMs or aneurysms, or thrombectomy to remove blood clots in acute stroke. Another important neurovascular intervention is surgical revascularization, which involves creating new blood flow pathways to bypass blocked or narrowed arteries in the brain. This may be done using techniques such as bypass surgery, where a healthy blood vessel from another part of the body is grafted to the affected area of the brain to restore blood flow. Neurovascular interventions also play a crucial role in the management of acute stroke, where rapid intervention is essential to minimize brain damage and improve outcomes. This may involve administering clot-busting medications such as tissue plasminogen activator (tPA) or performing mechanical thrombectomy to remove the clot causing the stroke. In addition to treating acute conditions, neurovascular interventions are also used for preventive purposes, such as treating asymptomatic aneurysms or arteriovenous malformations to prevent rupture or hemorrhage.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom